The benefits of the Johnson & Johnson Janssen coronavirus vaccine still outweigh potential risks, according to data from the US Centers for Disease Control and Prevention.
CDC advisers will meet Thursday to discuss need for coronavirus boosters and J&J vaccine safety"Many hospitalizations, ICU admissions and deaths can be prevented through Janssen and mRNA Covid-19 vaccines, far outweighing the risks," CDC researcher Dr. Hannah Rosenblum told the agency's Advisory Committee on Immunization Practices in a meeting on Thursday. The Pfizer/BioNTech and Moderna vaccines are messenger RNA or mRNA vaccines.
"There are a lot of people who really just want the one -- the single-dose vaccine," said ACIP member Dr. Sharon Frey, who is a vaccine specialist at St Louis University Medical School. "The risk-benefit leans towards benefit of receiving these vaccines in so many ways," Frey added.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
J&J forecasts $2.5B in revenue from Covid vaccine sales during 2021Although Johnson & Johnson raised its 2021 revenue estimates, its vaccine sales outlook pales in comparison with its peers, reflecting the widening gap in the global vaccine race.
Leer más »
If you got the Johnson & Johnson vaccine, do you need another dose?There's growing anxiety over the highly contagious delta variant in the U.S.
Leer más »
Johnson & Johnson Vaccine Far Less Effective Against Delta Variant, Study SuggestsMore than 13 million Americans have received the J&J vaccine.
Leer más »
J&J Vaccine Less Effective Against Variants: StudyA new study says the one-dose Johnson & Johnson vaccine provides less protection against the Delta and Lamba variants than against the original COVID-19 strain.
Leer más »
As Florida cases surge, DeSantis stays the course on CovidCoronavirus rates are climbing in Florida, with the latest data showing Florida's current seven-day average of new daily Covid-19 cases is by far the highest in the nation.
Leer más »
Johnson & Johnson expects $2.5 billion in global sales from Covid vaccine this yearJ&J says it expects to sell $2.5 billion of its Covid-19 vaccine this year — CFO Joseph Wolk joined megtirrell to discuss Q2 results, the spread of the delta variant and more.
Leer más »